Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06510218 · ClinicalTrials.gov registry record
The 2021-2022 Study of Family and Staff Well-Being in Head Start AIAN FACES Programs
A clinical trial, sponsored by Mathematica Policy Research.
- Completed
- Registry status
- 560
- Enrollment target
NCT06510218: Completed study, sponsored by Mathematica Policy Research.
NCT06510218 is a clinical trial that has completed, run by Mathematica Policy Research. The registered enrollment target is 560 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06510218 has completed, sponsored by Mathematica Policy Research.
- COMPLETED
- Registry status
- 560 participants
- Enrollment target
Study Summary
The 2021-2022 Study of Family and Staff Experiences in American Indian and Alaska Native Head Start Family and Child Experiences Survey Programs (the 2021-2022 Study) builds on AIAN FACES 2019, a national study of children and families participating in Head Start programs funded through grants to federally recognized tribes and consortia. In the year following the start of the COVID-19 pandemic, there was a need to understand how children, families, and Head Start staff were faring. The 2021-2022 Study explores this with some of the programs that participated in AIAN FACES 2019.
Primary Outcome
Indicators of physical well-being were assessed by parent report to a survey item on if child's health is excellent, very good, good, fair, or poor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 560 participants |
| Start Date | 2021-08-02 |
| Est. Completion | 2022-07-31 |
What the finished NCT06510218 record still lists
NCT06510218 is an observational study that tracks outcomes without assigning an intervention. The registered 560 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT06510218 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06510218 about?
NCT06510218 is a clinical study titled "The 2021-2022 Study of Family and Staff Well-Being in Head Start AIAN FACES Programs". The 2021-2022 Study of Family and Staff Experiences in American Indian and Alaska Native Head Start Family and Child Experiences Survey Programs (the 2021-2022 Study) builds on AIAN FACES 2019, a national study of children and families participating in Head Start programs funded through grants to fe...
What is the current status of trial NCT06510218?
This trial is currently completed. The enrollment target is 560 participants. The study started on 2021-08-02. Estimated completion is 2022-07-31.
Who is sponsoring clinical trial NCT06510218?
This trial is sponsored by Mathematica Policy Research, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04661358 · 560 participants · Phase 3
Fenofibrate for Prevention of DR Worsening
- NCT05473871 · 560 participants · NA
Enhancing Capacity in Churches to Implement PA Programs
- NCT06001541 · 560 participants · NA
Web-based Program to Improve Self-management Among Veterans-caregiver Dyads
- NCT06246916 · 560 participants · Phase 3
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI